Argenx appoints karl gubitz as chief financial officer

June 1, 2021 breda, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced the appointment of mr. karl gubitz as chief financial officer. mr. gubitz brings to argenx nearly 20 years of global pharmaceutical leadership experience, specifically in financial planning and analysis, business partnerships and product commercialization. he will succeed eric castaldi, who will remain with the company through june 30, 2021.
ARGX Ratings Summary
ARGX Quant Ranking